Groundbreaking Research Unveils Surge in US Interventional Radiology Market to $13.22+ Billion by 2031

The expansion of chronic disease awareness, coupled with a growing demand for image-guided treatments, is propelling the U.S. interventional radiology market. Additionally, an aging population experiencing heart, liver, gall bladder, and cancer issues is contributing to this growth. Balloon angioplasty dominated the market in 2021, while ambulatory surgical centers are expected to witness the highest CAGR by 2031.

The U.S. interventional radiology market, as per the report by Allied Market Research, reached USD 7.66 billion in 2021 and is projected to reach USD 13.22 billion by 2031, with a CAGR of 5.6% from 2022 to 2031. The report offers comprehensive insights into top investment opportunities, winning strategies, drivers, and market trends. It serves as a valuable resource for industry leaders, newcomers, investors, and stakeholders, aiding them in devising future strategies and strengthening their market position. With quantitative analysis spanning from 2022 to 2031, the report equips stakeholders to capitalize on existing market prospects in the U.S. interventional radiology sector.

Download Sample Report- https://www.alliedmarketresearch.com/request-sample/4873

The U.S. interventional radiology market undergoes a thorough analysis across various parameters including product type, procedure, application, and end-user, providing detailed insights through tabular and graphical representations. Investors and market players can leverage this breakdown to strategize based on high-revenue and fast-growing segments outlined in the report.

In terms of product type, the stents segment commanded nearly one-third of the market share in 2021 and is projected to maintain dominance by 2031, with a rapid CAGR of 6.6%. Other segments analyzed include Angiography & Angioplasty Devices, Embolization Devices, Biopsy Devices, and Ablation Devices.

Regarding procedures, balloon angioplasty contributed to almost one-third of the total market revenue in 2021 and is poised to lead until 2031. Meanwhile, the ablation segment is forecasted to exhibit the fastest CAGR of 7.8% throughout the forecast period. Additional segments studied encompass Angiography, Embolization, Biopsy, and Vertebroplasty-Kyphoplasty.

In terms of application, cardiology seized nearly half of the market revenue in 2021 and is projected to continue dominance by 2031. Conversely, the oncology segment is anticipated to showcase the fastest CAGR of 6.5% during the forecast period. Other segments assessed include Urology & Nephrology and Gastroenterology.

Lastly, in terms of end-users, hospitals generated over three-fifths of the total market revenue in 2021 and are expected to maintain the majority share by 2031. Simultaneously, ambulatory surgical centers are forecasted to manifest the fastest CAGR of 6.5% during the forecast period.

The key market players analyzed in the U.S. interventional radiology market report include 

Dickinson and Company, Cook Group Incorporated, Biosensor International Group, Ltd, Koninklijke Philips N.V., Hologic Inc., Becton, Stryker Corporation, Siemens Ag, Medtronic Plc., Boston Scientific Corporation, and Teleflex Incorporated.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/4873